GenMark Diagnostics Schedules First Quarter 2019 Financial Results Conference Call for April 30, 2019
15 avr. 2019 07h45 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its first quarter earnings results after market close...
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Negative Panel
15 avr. 2019 07h30 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...
GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results
21 févr. 2019 16h05 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced...
GenMark Diagnostics Announces Expansion of Executive Leadership Team
21 févr. 2019 16h03 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the...
GenMark Diagnostics to Participate in Upcoming Investor Conferences
20 févr. 2019 16h55 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...
GenMark Diagnostics Schedules Fourth Quarter and Full Year 2018 Financial Results Conference Call for February 21, 2019
07 févr. 2019 16h43 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its fourth quarter earnings results after market close...
GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2018
08 janv. 2019 08h00 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided...
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Fungal Pathogen Panel
26 déc. 2018 08h00 HE
|
GenMark Diagnostics, Inc.
Two of Three ePlex Blood Culture Identification Panels Now Cleared for Marketing in the U.S. CARLSBAD, Calif., Dec. 26, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading...
GenMark Diagnostics Receives FDA 510(k) Market Clearance for its ePlex Blood Culture Identification Gram-Positive Panel
20 déc. 2018 14h15 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it...
GenMark Diagnostics to Present at the J.P. Morgan Healthcare Conference
19 déc. 2018 17h22 HE
|
GenMark Diagnostics, Inc.
CARLSBAD, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the...